Stock Earnings

Question 1

What are Aligos Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Aligos Therapeutics Inc has a total asset of $70, Net loss of $-131

Question 2

What are the key financial ratios for ALGS?

Accepted Answer

Aligos Therapeutics Inc's Current ratio is 0.7, has a Net margin is -4,366.66, sales per share of $0.47.

Question 3

How is Aligos Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Aligos Therapeutics Inc data is not available.

Question 4

Is Aligos Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Aligos Therapeutics Inc has a net loss of $-131

Question 5

Does Aligos Therapeutics Inc have any liabilities?

Accepted Answer

yes, Aligos Therapeutics Inc has liability of 99

Question 6

How many outstanding shares for Aligos Therapeutics Inc?

Accepted Answer

Aligos Therapeutics Inc has a total outstanding shares of 3.98

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2	3	15	13	4	0
Revenue Growth (YoY)	-60%	-80%	15%	225%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	16	18	24	26	28	17
Research & Development	68	70	73	85	104	79
Operating Expenses	89	88	97	111	132	97
Other Non Operating Income (Expenses)	-1	-43	-3	0	0	-11
Pretax Income	-86	-130	-86	-95	-128	-108
Income Tax Expense	0	0	0	0	0	0
Net Income	-86	-131	-87	-96	-128	-108
Net Income Growth	13%	51%	-9%	-25%	19%	108%
Shares Outstanding (Diluted)	10.36	6.26	2.57	42.7	39.86	36.61
Shares Change (YoY)	65%	144%	-94%	7%	9%	-1%
EPS (Diluted)	-8.33	-20.94	-34.11	-2.25	-3.22	-2.97
EPS Growth	-32%	-39%	1,416%	-30%	8%	109%
Free Cash Flow	-79	-80	-79	-80	-116	-76
Free Cash Flow Per Share	-7.61	-12.77	-30.73	-1.87	-2.91	-2.07
Gross Margin	--	--	--	--	--	--
Operating Margin	-4,300%	-2,800%	-546.66%	-746.15%	-3,200%	0%
Profit Margin	-4,300%	-4,366.66%	-580%	-738.46%	-3,200%	0%
Free Cash Flow Margin	-3,950%	-2,666.66%	-526.66%	-615.38%	-2,900%	0%
EBITDA	-86	-83	-81	-95	-125	-95
EBITDA Margin	-4,300%	-2,766.66%	-540%	-730.76%	-3,125%	0%
D&A For EBITDA	0	1	1	2	3	2
EBIT	-86	-84	-82	-97	-128	-97
EBIT Margin	-4,300%	-2,800%	-546.66%	-746.15%	-3,200%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Aligos Therapeutics Inc (ALGS) Price